EXCLUSIVE: ‘People Love THCV Before The Gym’ Says Phylos Executive On Cannabis Genetics Advancements

In the latest episode of Benzinga’s Cannabis Insider, Phylos chief commercial officer Whitney Conroy shared groundbreaking developments in Phylos’ elite F1 hybrid seeds and their significant advancements in THCV research.

Phylos, a company leading in cannabis genetics and sustainable large-scale cultivation, has introduced elite F1 hybrid seeds.

These first-generation seeds are bred for consistency, offering growers uniform and reliable genetics.

“You could plant 1,000 seeds, and you’ll get almost the exact same genetic very uniform,” Conroy explained. This uniformity ensures a consistent consumer experience across different states, addressing a major challenge in the cannabis industry.

See Also: Roblox Stock Faces Death Cross As Mixed Earnings, Downgraded Outlook Signal Trouble Ahead

Conroy emphasized the benefits of these seeds for commercial-scale cultivation.

“The seeds produce high-quality, potent, and vigorous plants with exceptional flower quality and yield,” she noted. The stability and reliability of these seeds mark a significant advancement in cannabis cultivation, making it easier for growers to produce consistent and high-quality products.